Status:

UNKNOWN

Antisense Oligonucleotide for Spinal Muscular Atrophy

Lead Sponsor:

First Affiliated Hospital of Fujian Medical University

Collaborating Sponsors:

Fujian Medical University Union Hospital

Peking Union Medical College Hospital

Conditions:

Spinal Muscular Atrophy

Eligibility:

All Genders

1-50 years

Brief Summary

This is a longitudinal, multiple-center, observational study of patients genetically confirmed chromosome 5q SMA to monitor the efficacy, safety, tolerability of SPINRAZA® (nusinersen) for up to 24 mo...

Detailed Description

SPINRAZA® (nusinersen) is an antisense oligonucleotide (ASO) designed to treat SMA caused by mutations in chromosome 5q that lead to SMN protein deficiency. Nusinersen, approved by the FDA for treatme...

Eligibility Criteria

Inclusion

  • Patients genetically confirmed 5q SMA including types I, II and III, who are planning to initiate treatment with SPINRAZA® (nusinersen) as part of their clinical care plan.
  • Non-5q SMA patients undergoing clinical standard lumbar puncture
  • Non-SMA subjects including Asymptomatic carriers of SMA, relatives of SMA patients and carriers, and patients undergoing clinical standard lumbar puncture
  • Participants or Parent(s)/legal guardian(s) willing and able to complete the informed consent process

Exclusion

  • Contraindication for lumbar puncture
  • Inability to access intrathecal space for nusinersen injection

Key Trial Info

Start Date :

January 1 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 31 2024

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT05187260

Start Date

January 1 2022

End Date

January 31 2024

Last Update

January 26 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Department of Neurology, Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100010

2

Department of Pediatrics, Fujian Medical University Union Hospital

Fuzhou, Fujian, China, 350001

3

Department of Neurology, First Affiliated Hospital Fujian Medical University

Fuzhou, Fujian, China, 350005